HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+1.26%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.53B
AUM Growth
+$2.53B
(+6.8%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
46.8%
Holding
68
New
20
Increased
18
Reduced
11
Closed
15
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$115M |
| 2 |
Humana
HUM
|
$103M |
| 3 |
Elanco Animal Health
ELAN
|
$97.3M |
| 4 |
Bristol-Myers Squibb
BMY
|
$91.3M |
| 5 |
Abbott
ABT
|
$86.2M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$136M |
| 2 |
Haemonetics
HAE
|
$121M |
| 3 |
AGN
Allergan plc
AGN
|
$90.4M |
| 4 |
DexCom
DXCM
|
$87M |
| 5 |
Medtronic
MDT
|
$86.8M |
Sector Composition
| 1 | Healthcare | 93.16% |
| 2 | Technology | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IQVIA
IQV
$31.4B
| $41.2M | 1.6% |
255,944
-146,896
| -36% | -$23.6M |
|
|
VRAY
27
DELISTED
ViewRay, Inc.
VRAY
| $40.2M | 1.56% |
4,564,640
+372,090
| +9% | +$3.28M |
|
|
CHNG
28
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $39.3M | 1.52% |
+2,690,190
| New | +$39.3M |
|
29
CONMED
CNMD
$1.64B
| $39M | 1.51% |
455,190
+115,690
| +34% | +$9.9M |
|
|
BPMC
30
DELISTED
Blueprint Medicines
BPMC
| $36.1M | 1.4% |
+382,504
| New | +$36.1M |
|
31
Alnylam Pharmaceuticals
ALNY
$58.6B
| $34M | 1.32% |
+468,540
| New | +$34M |
|
32
Alcon
ALC
$38.9B
| $32.7M | 1.27% |
+526,840
| New | +$32.7M |
|
33
Becton Dickinson
BDX
$54.3B
| $30.6M | 1.19% |
124,302
-45,151
| -27% | -$11.1M |
|
|
RDUS
34
DELISTED
Radius Health, Inc.
RDUS
| $30.3M | 1.17% |
1,242,850
-2,438,099
| -66% | -$59.4M |
|
|
CLVS
35
DELISTED
Clovis Oncology, Inc.
CLVS
| $24.5M | 0.95% |
1,648,090
+249,790
| +18% | +$3.71M |
|
|
MYOK
36
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $17.6M | 0.68% |
350,620
-380,140
| -52% | -$19.1M |
|
|
STML
37
DELISTED
Stemline Therapeutics, Inc.
STML
| $16.4M | 0.64% |
+1,069,960
| New | +$16.4M |
|
38
Select Medical
SEM
$1.6B
| $15.9M | 0.62% |
1,865,094
+751,494
| +67% | +$6.43M |
|
|
NUVA
39
DELISTED
NuVasive, Inc.
NUVA
| $14.6M | 0.57% |
+249,720
| New | +$14.6M |
|
40
Centene
CNC
$14.8B
| $13.1M | 0.51% |
250,000
-766,400
| -75% | -$40.2M |
|
41
Tenet Healthcare
THC
$16.5B
| $8.8M | 0.34% |
+425,820
| New | +$8.8M |
|
42
Personalis
PSNL
$430M
| $8.15M | 0.32% |
+300,000
| New | +$8.15M |
|
43
Stryker
SYK
$149B
| $6.86M | 0.27% |
+33,350
| New | +$6.86M |
|
44
Adaptive Biotechnologies
ADPT
$1.96B
| $5.8M | 0.22% |
+120,000
| New | +$5.8M |
|
45
Ironwood Pharmaceuticals
IRWD
$201M
| $5.47M | 0.21% |
500,000
-392,154
| -44% | -$4.29M |
|
|
NGM
46
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $5.02M | 0.19% |
+342,579
| New | +$5.02M |
|
|
PTE
47
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $3.28M | 0.13% |
23,000
+7,000
| +44% | +$998K |
|
48
Acadia Pharmaceuticals
ACAD
$4.34B
| $3.19M | 0.12% |
+119,484
| New | +$3.19M |
|
|
WMGI
49
DELISTED
Wright Medical Group Inc
WMGI
| $2.98M | 0.12% |
100,000
-1,086,830
| -92% | -$32.4M |
|
|
AXLA
50
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $1.59M | 0.06% |
+6,826
| New | +$1.59M |
|